Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria
Small · 2024
DOI: 10.1002/smll.202305764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Weijian Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Han…. Hauptthemen laut MEDLINE: Melanins, Immunotherapy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases.
Abstract (Originalsprache)
Photothermal therapy (PTT) is a new treatment modality for tumors. However, the efficient delivery of photothermal agents into tumors remains difficult, especially in hypoxic tumor regions. In this study, an approach to deliver melanin, a natural photothermal agent, into tumors using genetically engineered bacteria for image‐guided photothermal and immune therapy is developed. An Escherichia coli MG1655 is transformed with a recombinant plasmid harboring a tyrosinase gene to produce melanin nanoparticles. Melanin‐producing genetically engineered bacteria (MG1655‐M) are systemically administered to 4T1 tumor‐bearing mice. The tumor‐targeting properties of MG1655‐M in the hypoxic environment integrate the properties of hypoxia targeting, photoacoustic imaging, and photothermal therapeutic agents in an “all‐in‐one” manner. This eliminates the need for post‐modification to achieve image‐guided hypoxia‐targeted cancer photothermal therapy. Tumor growth is significantly suppressed by irradiating the tumor with an 808 nm laser. Furthermore, strong antitumor immunity is triggered by PTT, thereby producing long‐term immune memory effects that effectively inhibit tumor metastasis and recurrence. This work proposes a new photothermal and immune therapy guided by an “all‐in‐one” melanin‐producing genetically engineered bacteria, which can offer broad potential applications in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310030, P. R. China.
- Bengbu Medical University, Bengbu, Anhui, 233030, P. R. China.
- Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen,…
- Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266000, P. R. China.
- School of Public Health, Nanchang University, Nanchang, Jiangxi, 330019, P. R. China.
ORCID-Profile: Weijian Song, Fei Yan, Litao Sun
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases
- Shenzhen Medical Research Fund
- National Basic Research Program of China
Zitieren
APA
Song, W., He, Y., Feng, Y., Wang, Y., Li, X., Wu, Y., Zhang, S., Zhong, L., Yan, F., & Sun, L. (2024). Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria. Small. https://doi.org/10.1002/smll.202305764
Vancouver
Song W, He Y, Feng Y, Wang Y, Li X, Wu Y, et al. Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria. Small. 2024. doi:10.1002/smll.202305764
BibTeX
@article{Song2024,
author = {Song, Weijian and He, Yaling and Feng, Yanan and Wang, Yuanyuan and Li, Xiaoying and Wu, Yingnan and Zhang, Shanxin and Zhong, Lin and Yan, Fei and Sun, Litao},
title = {Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202305764}
}
EUVIMED